Last 12 months
Inside the activity.
7 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 2 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2017 Filed Sep 19, 2017 18:36 UTC |
Durkin Bryan TPresident
|
GrantCommon Stock Class A | 9,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000093 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,878 Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:35 UTC |
DUFFY TERRENCE ADirector · Chairman and CEO
|
Tax withholdingCommon Stock Class A | 5,285 | $131.29 | $693,867.65 |
DisclosureSEC source: 0001156375-17-000092 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,418 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:35 UTC |
DUFFY TERRENCE ADirector · Chairman and CEO
|
GrantCommon Stock Class A | 19,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000092 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,703 Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:35 UTC |
Cutinho SunilSr MD & President CME Clearing
|
Tax withholdingCommon Stock Class A | 1,369 | $131.29 | $179,736.01 |
DisclosureSEC source: 0001156375-17-000091 · edgardoc.xml · nonDerivative · entry 2 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,177 F1 · shares: Mr. Cutinho surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:35 UTC |
Cutinho SunilSr MD & President CME Clearing
|
GrantCommon Stock Class A | 4,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000091 · edgardoc.xml · nonDerivative · entry 1 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,546 Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:34 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Tax withholdingCommon Stock Class A | 1,374 | $131.29 | $180,392.46 |
DisclosureSEC source: 0001156375-17-000090 · edgardoc.xml · nonDerivative · entry 2 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,459 F1 · shares: Ms. Cronin surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:34 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
GrantCommon Stock Class A | 4,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000090 · edgardoc.xml · nonDerivative · entry 1 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,833 Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 16:15 UTC |
Suskind DennisDirector
|
SaleCommon Stock Class A | 750 | $129.34 | $97,005.00 |
DisclosureSEC source: 0001156375-17-000089 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,059 F1 · price: On September 11, 2017, Mr. Suskind sold an aggregate of 750 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $129.07 to $129.60. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 18:40 UTC |
Piell Hilda HarrisSr MD & Chief HR Officer
|
SaleCommon Stock Class A | 714 | $129.00 | $92,106.00 |
DisclosureSEC source: 0001156375-17-000088 · edgardoc.xml · nonDerivative · entry 1 Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,844 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 21:33 UTC |
GLICKMAN DANIEL RDirector
|
SaleCommon Stock Class A | 850 | $126.65 | $107,652.50 |
DisclosureSEC source: 0001156375-17-000087 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,799 Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:12 UTC |
GEPSMAN MARTIN JDirector
|
SaleCommon Stock Class A | 200 | $126.14 | $25,228.00 |
DisclosureSEC source: 0001156375-17-000085 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,311 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 15:41 UTC |
Durkin Bryan TPresident
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,200 | $0.00 Strike: $109.72 | $0.00 |
DisclosureSEC source: 0001156375-17-000084 · edgardoc.xml · derivative · entry 3 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 9,200 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: As of September 14, 2012, this option vested with respect to 100% of the option. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 15:41 UTC |
Durkin Bryan TPresident
|
SaleCommon Stock Class A | 9,200 | $125.13 | $1,151,178.52 |
DisclosureSEC source: 0001156375-17-000084 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,738 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 15:41 UTC |
Durkin Bryan TPresident
|
Exercise / conversionCommon Stock Class A | 9,200 | $109.72 | $1,009,424.00 |
DisclosureSEC source: 0001156375-17-000084 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 19:24 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,875 | $0.00 Strike: $83.88 | $0.00 |
DisclosureSEC source: 0001156375-17-000083 · edgardoc.xml · derivative · entry 6 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 5,875 shares Expires 2018-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: As of June 16, 2013, this option vested with respect to 100% of the option. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 19:24 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,040 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001156375-17-000083 · edgardoc.xml · derivative · entry 5 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 6,040 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of September 15, 2013, this option vested with respect to 100% of the option. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 19:24 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
SaleCommon Stock Class A | 6,040 | $125.67 | $759,052.24 |
DisclosureSEC source: 0001156375-17-000083 · edgardoc.xml · nonDerivative · entry 4 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,782 F1 · price: On August 7, 2017, Ms. Holzrichter sold a total of 11,915 shares of CME Group Class A common stock at an average price of $125.67 per share, including the exercise of options. The price ranges were $125.65 through $125.70. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 19:24 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
Exercise / conversionCommon Stock Class A | 6,040 | $56.87 | $343,494.80 |
DisclosureSEC source: 0001156375-17-000083 · edgardoc.xml · nonDerivative · entry 3 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 19:24 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
SaleCommon Stock Class A | 5,875 | $125.67 | $738,316.54 |
DisclosureSEC source: 0001156375-17-000083 · edgardoc.xml · nonDerivative · entry 2 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,782 F1 · price: On August 7, 2017, Ms. Holzrichter sold a total of 11,915 shares of CME Group Class A common stock at an average price of $125.67 per share, including the exercise of options. The price ranges were $125.65 through $125.70. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 19:24 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
Exercise / conversionCommon Stock Class A | 5,875 | $83.88 | $492,795.00 |
DisclosureSEC source: 0001156375-17-000083 · edgardoc.xml · nonDerivative · entry 1 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2017 Filed Aug 3, 2017 20:17 UTC |
Pankau Ronald A.Director
|
SaleCommon Stock Class A | 300 | $124.78 | $37,434.00 |
DisclosureSEC source: 0001156375-17-000082 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009 Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 20:17 UTC |
DUFFY TERRENCE ADirector · Chairman and CEO
|
SaleCommon Stock Class A | 21,815 | $123.89 | $2,702,660.35 |
DisclosureSEC source: 0001156375-17-000081 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,711 F1 · price: On August 2, 2017, Mr. Duffy sold an aggregate of 21,815 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $123.80 to $123.99 and $124.19 to $124.22. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| July 18, 2017 Filed Feb 6, 2018 22:27 UTC |
POLLOCK ALEX JDirector
|
GiftCommon Stock Class A | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000010 · edgardoc.xml · nonDerivative · entry 2 POLLOCK ALEX J · CIK 0001234604 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 2,719 Read SEC document |
| July 18, 2017 Filed Feb 6, 2018 22:27 UTC |
POLLOCK ALEX JDirector
|
GiftCommon Stock Class A | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000010 · edgardoc.xml · nonDerivative · entry 1 POLLOCK ALEX J · CIK 0001234604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,706 F1 · shares: This transaction involved a gift of securities by the reporting person to his spouse, who shares reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his spouse, and this report should not be deemed as an admission that the reporting person is the beneficial owner of his spouse's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 10, 2017 Filed Jul 10, 2017 21:26 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
SaleCommon Stock Class A | 2,500 | $124.50 | $311,250.00 |
DisclosureSEC source: 0001156375-17-000077 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,495 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 18:00 UTC |
GERDES LARRY GDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000069 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,605.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 17:59 UTC |
SAVAGE TERRY LDirector
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000062 · edgardoc.xml · nonDerivative · entry 1 SAVAGE TERRY L · CIK 0001094549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,833 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:01 UTC |
CHOOKASZIAN DENNISDirector
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000073 · edgardoc.xml · nonDerivative · entry 1 CHOOKASZIAN DENNIS · CIK 0001120026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:02 UTC |
Bernacchi Jeffrey M.Director
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000076 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:02 UTC |
Bitsberger Timothy S.Director
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000075 · edgardoc.xml · nonDerivative · entry 1 Bitsberger Timothy S. · CIK 0001434852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,833 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:01 UTC |
Carey Charles PDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000074 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,294 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:01 UTC |
Cook Elizabeth ADirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000072 · edgardoc.xml · nonDerivative · entry 1 Cook Elizabeth A · CIK 0001643475 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 20,933 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:01 UTC |
Dutra AnaDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000071 · edgardoc.xml · nonDerivative · entry 1 Dutra Ana · CIK 0001426393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,433 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:00 UTC |
GEPSMAN MARTIN JDirector
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000070 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,511 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:00 UTC |
GLICKMAN DANIEL RDirector
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000068 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,649 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:00 UTC |
Hertshten GedonDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000067 · edgardoc.xml · nonDerivative · entry 1 Hertshten Gedon · CIK 0001708032 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,572 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:00 UTC |
MELAMED LEODirector
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000066 · edgardoc.xml · nonDerivative · entry 1 MELAMED LEO · CIK 0001212838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,837 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:59 UTC |
Pankau Ronald A.Director
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000065 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,309 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:59 UTC |
POLLOCK ALEX JDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000064 · edgardoc.xml · nonDerivative · entry 1 POLLOCK ALEX J · CIK 0001234604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,906 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:59 UTC |
SANDNER JOHN FDirector
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000063 · edgardoc.xml · nonDerivative · entry 1 SANDNER JOHN F · CIK 0001212848 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,218 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:58 UTC |
SHEPARD WILLIAM RDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000061 · primary_doc.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,108 F3 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:58 UTC |
SIEGEL HOWARD JDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000060 · edgardoc.xml · nonDerivative · entry 1 SIEGEL HOWARD J · CIK 0001212853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,239 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:58 UTC |
Suskind DennisDirector
|
GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000059 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,809 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:58 UTC |
WESCOTT DAVID JDirector
|
GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000058 · edgardoc.xml · nonDerivative · entry 1 WESCOTT DAVID J · CIK 0001229218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,565 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 19:14 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,625 | $0.00 Strike: $83.88 | $0.00 |
DisclosureSEC source: 0001156375-17-000056 · edgardoc.xml · derivative · entry 6 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 6,625 shares Expires 2018-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of 6/16/2013, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 19:14 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001156375-17-000056 · edgardoc.xml · derivative · entry 5 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,320 Underlying: Common Stock Class A · 1,500 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: As of 9/15/2013, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 19:14 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
SaleCommon Stock Class A | 1,500 | $127.35 | $191,020.35 |
DisclosureSEC source: 0001156375-17-000056 · edgardoc.xml · nonDerivative · entry 4 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,549 Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 19:14 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionCommon Stock Class A | 1,500 | $56.87 | $85,305.00 |
DisclosureSEC source: 0001156375-17-000056 · edgardoc.xml · nonDerivative · entry 3 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 19:14 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
SaleCommon Stock Class A | 6,625 | $127.35 | $843,673.21 |
DisclosureSEC source: 0001156375-17-000056 · edgardoc.xml · nonDerivative · entry 2 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,549 Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 19:14 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionCommon Stock Class A | 6,625 | $83.88 | $555,705.00 |
DisclosureSEC source: 0001156375-17-000056 · edgardoc.xml · nonDerivative · entry 1 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.